Back to Search
GINA RANIERI, DO
DO
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
NPI: 1386148773IndividualAccepts Medicare
Specialties, Licenses & Credentials
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) PhysicianPrimary
Obstetrics & Gynecology — Urogynecology and Reconstructive Pelvic Surgery
Code: 207VF0040X
25MB12280200(NJ)
CMS Specialties
PrimaryOBSTETRICS/GYNECOLOGY
Education
PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE
Class of 2018
Research & Publications (20)
Charge screening in the S(N)2 reaction of charged electrophiles and charged nucleophiles: an ionic liquid effect.
PMID 19178145·J Org Chem·2009
8-other
Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients.
PMID 19513558·Int J Oncol·2009
8-other
VEGF concentration from plasma-activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous model.
PMID 18429933·J Cell Mol Med·2009
7-preclinical
High occurrence of Helicobacter pylori in raw goat, sheep and cow milk inferred by glmM gene: a risk of food-borne infection?
PMID 18372071·Int J Food Microbiol·2008
7-preclinical
May antioxidant therapy improve sperm parameters of men with persistent oligospermia after retrograde embolization for varicocele?
PMID 17982752·World J Urol·2008
4-observational
Ejaculatory duct obstruction caused by a right giant seminal vesicle with an ipsilateral upper urinary tract agenesia: an embryologic malformation.
PMID 17675001·Fertil Steril·2008
8-other
Gelation of charged bio-nanocompartments induced by associative and non-associative polysaccharides.
PMID 18621514·Colloids Surf B Biointerfaces·2008
8-other
Expression of proto-oncogene C-kit and correlation with morphological evaluations in canine cutaneous mast cell tumors.
PMID 18608529·Immunopharmacol Immunotoxicol·2008
7-preclinical
Thymidine phosphorylase (platelet-derived endothelial cell growth factor) as a target for capecitabine: from biology to the bedside.
PMID 18221035·Recent Pat Anticancer Drug Discov·2006
6-review
Can a decreasing ultrafiltration profile affect the dialytic dose administered?
PMID 17096702·Ther Apher Dial·2006
8-other
Drug targets to pro-angiogenetic factors with special reference to primary peritoneal mesothelioma.
PMID 17017978·Endocr Metab Immune Disord Drug Targets·2006
6-review
H pylori status and angiogenesis factors in human gastric carcinoma.
PMID 17006982·World J Gastroenterol·2006
8-other
Long-term effects of tibolone on circulating levels of vascular cell adhesion molecules and E-selectin in postmenopausal women.
PMID 16963035·Fertil Steril·2006
2-rct
Is the efficacy of LDL apheresis in ischemic optic neuropathy linked to a reduction in endothelial activation markers?
PMID 16847390·Blood Purif·2006
8-other
Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic.
PMID 16842197·Curr Med Chem·2006
6-review
Microvascular density and endothelial area correlate with Ki-67 proliferative rate in the canine non-Hodgkin's lymphoma spontaneous model.
PMID 16840207·Leuk Lymphoma·2006
7-preclinical
Does a reduction of adhesion molecules by LDL-apheresis have a role in the treatment of sudden hearing loss?
PMID 16817795·Ther Apher Dial·2006
5-case
Endothelial area and microvascular density in a canine non-Hodgkin's lymphoma: an interspecies model of tumor angiogenesis.
PMID 16236617·Leuk Lymphoma·2005
4-observational
Development of vasculature targeting strategies for the treatment of chronic inflammatory diseases.
PMID 15720230·Curr Drug Targets Inflamm Allergy·2005
6-review
Thymidine phosphorylase profiles in nonmalignant and malignant pancreatic tissue. Potential therapeutic role of capecitabine on tumoral and endothelial cells and tumor-infiltrating macrophages.
PMID 15803863·Immunopharmacol Immunotoxicol·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 800 BUNN DR STE 202
PRINCETON, NJ 08540 - Phone
- (609) 430-1900
Quick Facts
- NPI
- 1386148773
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 8
- Publications
- 20
Are you this provider?
Claim Your Profile